| Financial Year |
March 31 2023 |
| Monetary Funds |
324,650,295.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,995,813.18 |
| Accounts Receivable |
420,950,419.93 |
| Advances to Suppliers |
5,373,408.89 |
| Other Receivables |
20,995,424.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
329,841,023.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,850,470.75 |
| Total Current Assets |
1,121,076,046.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
46,211.88 |
| Long-term Equity Investment |
-- |
| Investment Properties |
25,637,658.19 |
| Fixed Assetes |
103,184,028.45 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,026,932.89 |
| R&D expenses |
6,777,034.85 |
| Goodwill |
320.00 |
| Long-Term Deferred and Prepaid Expenses |
897,551.09 |
| Deferred Income Tax Assets |
17,491,895.98 |
| Other Non-Current Assets |
54,201,828.88 |
| Sub-Total of Non-Current Assets |
250,374,666.26 |
| Total Assets |
1,371,450,713.01 |
| Short-Term Loans |
23,511,033.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
150,242,206.59 |
| Accounts Payable |
-- |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,005,553.74 |
| Taxes Payable |
3,503,076.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,632,259.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,287,272.83 |
| Other Current Liabilities |
31,282,156.44 |
| Sub-Total of Current Liabilities |
270,313,372.65 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,610,320.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,337,056.91 |
| Total Liabilities |
282,650,429.56 |
| Paid-In Capital(Or Share Stock) |
272,570,030.00 |
| Capital Surplus |
381,115,504.17 |
| Surplus Reserve |
41,478,442.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
382,505,611.99 |
| Minority Stockholder's Interest |
14,429,272.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,074,371,010.79 |
| Owner's Equity（Stockholder's Equity） |
1,088,800,283.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,371,450,713.01 |
